600+ sources. One page. See who else covered it.
Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its marketed range.
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
China's Services Purchasing Managers' Index (PMI) declined to 50.4 in July from 54.1 in June, the latest data published by RatingDog showed on Wednesday.
Australia’s stock benchmark briefly climbed to an intraday record on easing concerns over the US-Iran conflict and supportive signals in the domestic economy.
Stocks rallied on Tuesday as the S&P 500 and the Dow Industrials closed at new records.
Unitree's customers include utilities, energy firms, universities, and research institutions.